Skip to main content
. 2021 Jun 19;9(8):4068–4075. doi: 10.1002/fsn3.2226

TABLE 2.

Comparison of prescribed anti‐COVID‐19 regimens between treatment and placebo group

Anti‐COVID−19 regimen Treatment Placebo p valuea
HCQ (%) 0 10 0.215
Azithromycin + HCQ (%) 30 13.33
Azithromycin + HCQ+naproxen (%) 13.33 26.67
Azithromycin + naproxen (%) 20 20
HCQ + naproxen (%) 10 3.33
Naproxen (%) 0 3.33
Azithromycin (%) 26.67 23.33

HCQ: hydroxycholorquine.

a

Fisher's exact test, p < 0.05 is considered significant.